Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
Yseop’s first CMC-focused offering automates the Quality Overall Summary (Module 2.3), a central component of regulatory submissions that pulls structured insights from Module 3.2.
Yseop Expands into CMC: Redefining Regulatory Automation Beyond Clinical Read More »
The FDA has begun using generative AI to review drug submissions, signaling a major shift in regulatory review. Learn how this impacts pharma teams and what it takes to make your content AI-ready.
The AI landscape is evolving rapidly. While pre-configured workflows have powered automation for years, the next frontier lies in intelligent AI agents—systems that can plan, adapt and execute tasks dynamically rather than following static scripts.
From Workflows to AI Agents: The Next Evolution in Automation Read More »
Milestones and partnerships showcase the company’s role as a trusted partner for AI-driven innovation in the pharmaceutical industry.
Yseop Kicks Off 2025 by Strengthening Its Leadership in Generative AI for Life Sciences Read More »
See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
Biopharma 2025: The AI Revolution in Healthcare Read More »
See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.
Reflecting on 2024: A Year of Innovation, Impact, and Progress in Life Sciences Read More »
In the high-stakes biopharma industry, the ability to produce accurate, compliant documents quickly can mean the difference between timely patient access to life-saving treatments and costly delays.
How Automation is Transforming Regulatory and Medical Writing in Biopharma Read More »
Explore how Yseop transitioned from AWS SageMaker to AWS Bedrock to overcome scalability challenges and enhance its generative AI capabilities. This strategic move accelerates innovation in regulatory document generation, empowering the pharmaceutical industry with cutting-edge, scalable solutions.
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live! Discover how Generative AI is transforming drug discovery, accelerating clinical trials, and streamlining regulatory submissions. Download now.
Strategic Choices for AI in Biopharma: Partnering for Effective Implementation Read More »
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live!
Harness the Power of Generative AI in Pharma: A Sneak Peek at Our Whitepaper Read More »